{"organizations": [], "uuid": "667e280b340d4195304b4de2af1808fb3abdc4d0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/bayer-results/bayer-cuts-full-year-guidance-on-strong-euro-idUSFWN1SA05U", "country": "US", "domain_rank": 408, "title": "Bayer cuts full-year guidance on strong euro", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-03T08:52:00.000+03:00", "replies_count": 0, "uuid": "667e280b340d4195304b4de2af1808fb3abdc4d0"}, "author": "", "url": "https://www.reuters.com/article/bayer-results/bayer-cuts-full-year-guidance-on-strong-euro-idUSFWN1SA05U", "ord_in_thread": 0, "title": "Bayer cuts full-year guidance on strong euro", "locations": [], "entities": {"persons": [{"name": "edward taylor", "sentiment": "none"}], "locations": [{"name": "frankfurt", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "bayer", "sentiment": "negative"}, {"name": "ludwig burger editing", "sentiment": "none"}, {"name": "ebitda", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 3, 2018 / 5:54 Bayer cuts full-year guidance on strong euro Reuters Staff 1 Min Read\nFRANKFURT, May 3 (Reuters) - German drug and crop chemical Bayer on Thursday cut its full-year guidance as a stronger euro weighs on the value of overseas revenues.\nSales would likely decline in 2018 in the low single-digit percentage range to below 35 billion euros ($42 billion), where it had previously predicted about 35 billion euros for the year.\nEarnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs, were set to decline by a low-single-digit percentage and not match the prior-year level, as previously forecast.\nBayerâ€™s adjusted (EBITDA) for the first quarter slipped 5 percent to 2.90 billion euros, hurt by a drop in sales of consumer care products. That was slightly higher than the average forecast by analysts of 2.83 billion euros. ($1 = 0.8343 euros) (Reporting by Ludwig Burger Editing by Edward Taylor)", "external_links": [], "published": "2018-05-03T08:52:00.000+03:00", "crawled": "2018-05-03T09:04:19.003+03:00", "highlightTitle": ""}